Michael R. Minogue - 31 Mar 2022 Form 4 Insider Report for ABIOMED INC

Role: CHAIRMAN, PRESIDENT, CEO, Director
Signature: /s/ Marc A. Began (by power of attorney)
Issuer symbol: N/A
Transactions as of: 31 Mar 2022
Net transactions value: $0
Form type: 4
Filing time: 04 Apr 2022, 17:14:57 UTC
Previous filing: 26 May 2022
Next filing: 27 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NASD	Common Stock $.01 par value	Award	$0	+43	+0.02%	$0.000000	229,806	31 Mar 2022	Direct	F1
holding	NASD	Common Stock $.01 par value						52,555	31 Mar 2022	By Trust - A
holding	NASD	Common Stock $.01 par value						73,745	31 Mar 2022	By Trust - B
holding	NASD	Common Stock $.01 par value						32,810	31 Mar 2022	By Trust - C
holding	NASD	Common Stock $.01 par value						655	31 Mar 2022	By Trust - D
holding	NASD	Common Stock $.01 par value						38,560	31 Mar 2022	By Trust - E
holding	NASD	Common Stock $.01 par value						85,040	31 Mar 2022	By Trust - F

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	NASD	Stock Option (right to buy)						85,000	31 Mar 2022	Common Stock	0	$21.55	Direct	F2, F3
holding	NASD	Stock Option (right to buy)						35,000	31 Mar 2022	Common Stock	0	$66.25	Direct	F2, F3
holding	NASD	Stock Option (right to buy)						30,500	31 Mar 2022	Common Stock	0	$99.62	Direct	F3, F4
holding	NASD	Stock Option (right to buy)						33,000	31 Mar 2022	Common Stock	0	$134.51	Direct	F3, F4
holding	NASD	Stock Option (right to buy)						30,000	31 Mar 2022	Common Stock	0	$381.97	Direct	F3, F4
holding	NASD	Stock Option (Right to Buy)						50,000	31 Mar 2022	Common Stock	0	$266.39	Direct	F3, F4
holding	NASD	Stock Option (Right to Buy)						20,898	31 Mar 2022	Common Stock	0	$223.90	Direct	F3, F4
holding	NASD	Stock Option (Right to Buy)						30,000	31 Mar 2022	Common Stock	0	$283.88	Direct	F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares of common stock were acquired by the reporting person through participation in the ABIOMED, Inc. Employee Stock Purchase Plan, qualified under Section 423 of the Internal Revenue Code, and the transaction was exempt under Rule 16b-3(c).
F2	Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
F3	These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
F4	. Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.